Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

519 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world prevalence of PD-L1 expression in non-small cell lung cancer: an Australia-wide multi-centre retrospective observational study.
Russell PA, Farrall AL, Prabhakaran S, Asadi K, Barrett W, Cooper C, Cooper W, Cotton S, Duhig E, Egan M, Fox S, Godbolt D, Gupta S, Hassan A, Leslie C, Leong T, Moffat D, Qiu MR, Sivasubramaniam V, Skerman J, Snell C, Walsh M, Whale K, Klebe S. Russell PA, et al. Among authors: prabhakaran s. Pathology. 2023 Dec;55(7):922-928. doi: 10.1016/j.pathol.2023.08.008. Epub 2023 Sep 27. Pathology. 2023. PMID: 37833206 Free article.
Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer.
Martini C, Logan JM, Sorvina A, Prabhakaran S, Ung BSY, Johnson IRD, Hickey SM, Brooks RD; kConFab Consortium; Caruso MC, Klebe S, Karageorgos L, O'Leary JJ, Delahunt B, Samaratunga H, Brooks DA. Martini C, et al. Among authors: prabhakaran s. Virchows Arch. 2024 Oct;485(4):723-728. doi: 10.1007/s00428-023-03643-1. Epub 2023 Sep 14. Virchows Arch. 2024. PMID: 37704825 Free PMC article.
Publisher Correction to: Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer.
Martini C, Logan JM, Sorvina A, Prabhakaran S, Ung BS, Johnson IRD, Hickey SM, Brooks RD; kConFab Consortium; Caruso MC, Klebe S, Karageorgos L, O'Leary JJ, Delahunt B, Samaratunga H, Brooks DA. Martini C, et al. Among authors: prabhakaran s. Virchows Arch. 2023 Sep 29. doi: 10.1007/s00428-023-03666-8. Online ahead of print. Virchows Arch. 2023. PMID: 37773453 No abstract available.
Altered endosomal-lysosomal biogenesis in melanoma.
Lam GT, Sorvina A, Martini C, Prabhakaran S, Ung BS, Lazniewska J, Moore CR, Beck AR, Hopkins AM, Johnson IRD, Caruso MC, Hickey SM, Brooks RD, Jackett L, Karageorgos L, Foster-Smith EJ, Malone V, Klebe S, O'Leary JJ, Brooks DA, Logan JM. Lam GT, et al. Among authors: prabhakaran s. Neoplasia. 2023 Sep;43:100924. doi: 10.1016/j.neo.2023.100924. Epub 2023 Aug 9. Neoplasia. 2023. PMID: 37562257 Free PMC article.
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical Trial.
Partridge AH, Hyslop T, Rosenberg SM, Bennett AV, Drier S, Jonsson M, Shimada A, Li Y, Li Y, Lynch T, Frank E, Collyar D, Basila D, Pinto D, Weiss A, Wolf A, Norris K, Witten M, Boisvert M, Giuliano A, Larson KE, Yost K, McAuliffe PF, Krie A, Tamirisa N, Darai S, Carey L, Thompson A, Hwang ES; COMET Study Consortium. Partridge AH, et al. JAMA Oncol. 2024 Dec 12. doi: 10.1001/jamaoncol.2024.6556. Online ahead of print. JAMA Oncol. 2024. PMID: 39665588
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.
Hwang ES, Hyslop T, Lynch T, Ryser MD, Weiss A, Wolf A, Norris K, Witten M, Grimm L, Schnitt S, Badve S, Factor R, Frank E, Collyar D, Basila D, Pinto D, Watson MA, West R, Davies L, Donovan JL, Shimada A, Li Y, Li Y, Bennett AV, Rosenberg S, Marks J, Winer E, Boisvert M, Giuliano A, Larson KE, Yost K, McAuliffe PF, Krie A, Tamirisa N, Carey LA, Thompson AM, Partridge AH; COMET Study Investigators. Hwang ES, et al. JAMA. 2024 Dec 12. doi: 10.1001/jama.2024.26698. Online ahead of print. JAMA. 2024. PMID: 39665585
Fourth-generation Pipeline™ Vantage flow diversion: First reported US experience of safety and feasibility.
Sweid A, Chahine A, Hage S, Morsi RZ, Thind S, Karar L, Baskaran A, Carrión-Penagos J, Desai H, Kothari SA, Rana R, Verhagen Metman O, Zakaria J, Siegler JE, Awad I, Hurley MC, Prabhakaran S, Polster S, Kass-Hout T. Sweid A, et al. Among authors: prabhakaran s. Interv Neuroradiol. 2024 Dec 5:15910199241301119. doi: 10.1177/15910199241301119. Online ahead of print. Interv Neuroradiol. 2024. PMID: 39635842 Free PMC article.
519 results